FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

NORAD Launches US Fighter Jets as Russian Military Aircraft Enter American Air Defense Identification Zone

Virginia Dems mandate Jan. 6 be taught as ‘violent insurrection,’ ban election fraud claims in schools

Trump Turns Up Heat on Republicans, Pressures Them to Pass SAVE Act: ‘Country Defining Fight for the Soul of Our Nation!’

Pentagon policy chief grilled as Dem claims Trump broke promise about going to war with Iran

Georgia sheriff arrested on DUI charge after blood alcohol content was allegedly almost triple legal limit

Small plane crashes into Phoenix home minutes after takeoff, injuring 3

‘Third-party’ auditor investigating Minnesota fraud received millions in state Medicaid funds

Macron vows nuclear arsenal boost as Europe turns to nukes amid rising global threats

‘Under siege’: Inside the growing radical Islam threat critics say is hiding in plain sight in deep red Texas

Walz-Ellison administration ‘enabled’ Minnesota’s fraud scandal: Guy Benson

NYC Dept of Education employee arrested, charged with murder of Bronx father

Savannah Guthrie returns to ‘Today’ show studio for first time since mother went missing

Iran widens regional war with first strike into Azerbaijan

5 House Oversight Committee Republicans Join with Democrats to Subpoena Pam Bondi in Epstein Probe

As Jasmine Crockett Concedes Texas Senate Primary, Attention Focuses on Radical Dem Who Beat Her

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”